DRL
Location
Vlaams Brabant
Founded
1980-09-05
Website
Risk Signals
105 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Furniture, Catalog and Mail-Order Houses), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about DRL
Live alerts from global media, monitored by Business Radar
2024-05-08 (livemint.com)
New businesses and partnerships hold the key to Dr Reddy's growth | Stock Market News
With a crucial product in the US set to go off-patent in January 2026, the company has adopted a multi-pronged strategy comprising partnerships, acquisitions and new products to boost revenue.
Read more
2024-04-23 (globenewswire.com)
Infinite Reality Acquires the Drone Racing League for $250 Million, Solidifying Position as Global Leader in Immersive Technology & Experiences
Acquisition of the Drone Racing League, the global, premier, professional sports property that merges the digital with the real, will accelerate Infinite...
Read more
2023-03-16 (business-standard.com)
Eris Life to acquire 9 dermatology brands from DRL
Eris Lifesciences announced that it will acquire part of the dermatology portfolio of Dr.Reddy's Laboratories by way of acquisition of nine trademarks along...
Read more
(thehindu.com)
DRL acquires Wockhardt divisions with amended pact -
COVID-19 impact on sales spurred change in agreement
Read more
(economictimes.com)
reddy: DRL acquires injectable portfolio from US-based Eton Pharma for $50 million -
The portfolio includes the Biorphen (phenylephrine hydrocholoride) injection and Rezipres (ephedrine hydrochloride) injection NDAs (new drug application) with nine separate combinations of strengths and presentations and one first- to-file approved ANDA for Cysteine Hydrochloride for the US.
Read more